Evrópusambandið - íslenska - EMA (European Medicines Agency)

dipharma arzneimittel gmbh - sapropterin díhýdróklóríð - phenylketonurias - Önnur meltingarvegi og efnaskipti vörur, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

Evrópusambandið - íslenska - EMA (European Medicines Agency)

laboratorios farmacéuticos rovi, s.a. - risperidone - geðklofa - psycholeptics - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lyfjaver ehf. - levodopum inn; entacaponum inn; carbidopum inn - filmuhúðuð tafla - 150 mg/37,5 mg/200 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - risperidonum inn - filmuhúðuð tafla - 1 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

evolan pharma ab - alimemazinum tartrat - hart hylki - 20 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 50 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 37,5 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 2,5 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 25 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - bupropionum hýdróklóríð - tafla með breyttan losunarhraða - 300 mg